Lovastatin production is dependent on the substrates provided. We investigated how several carbon and nitrogen sources in the medium affect lovastatin production by Monascus pilosus. M. pilosus required a suitable concentration of organic nitrogen peptone for high lovastatin production. As sole carbon source with peptone, although glucose strongly repressed lovastatin production, maltose was responsible for high production. Interestingly, glycerol combined with maltose enhanced lovastatin production, up to 444 mg/l in the most effective case. Moreover, an isolated mutant, in which glucose repression might be relieved, easily produced the highest level of lovastatin, 725 mg/l on glucose-glycerol-peptone medium. These observations indicate that lovastatin production by M. pilosus is regulated by strict glucose repression and that an appropriate release from this repression by optimizing medium composition and/or by a mutation(s) is required for high lovastatin production.
Statins such as lovastatin are inhibitors of the enzyme hydroxymethyglutaryl coenzyme A reductase, which catalyzes the rate-limiting step in cholesterol biosynthesis, resulting in lowered blood cholesterol. 1, 2) Lovastatin can be produced by Penicillium species, 3) Aspergillus terreus, 2) and Monascus species 4) via the polyketide pathway, which is responsible for synthesizing many secondary metabolites with complex chemical structures. The genes and the enzymes involved in lovastatin biosynthesis have been identified and characterized in A. terreus, 5, 6) and it is becoming apparent that both carbon and nitrogen sources regulate lovastatin biosynthesis at the level of glucose repression and signaling of growth or substrate limitations. 7, 8) These studies showed that two overlapping carbon source conditions are sufficient to allow high lovastatin production: growth resulting in carbon limitation, and nonglucose repression under nitrogen limitation. Information about the regulation of lovastatin biosynthesis should be useful for improving bioprocesses for high lovastatin production by A. terreus in the laboratory or in industry. 9) It is known that lovastatin production by Monascus species is also dependent on the culture conditions, because various bioprocess improvements have been attempted to achieve higher production, including incubation processes, solid-state fermentation, and selections of optimized strains and complex substrates provided. [10] [11] [12] [13] Little has been indicated about the regulation of lovastatin biosynthesis in this species, however. In order to improve lovastatin production, we focused on M. pilosus, since this species has long been popular for use in brewing foodstuffs in Japan. Although the lovastatin productivity of M. pilosus is thought still to be relatively low, this species has the advantage of lower risk of citrinin (a nephrotoxic agent) contamination, unlike M. ruber and M. purpureus. 14) But there has been no study on the influence of principal nutrients such as carbon and nitrogen on lovastatin production by M. pilosus.
In this study, we examined the effects of several carbon and nitrogen sources on lovastatin production to develop a defined medium for high production, and isolated a regulatory mutant which would serve to develop such a level of production. We found that the type and dose of carbon and nitrogen sources had a strong influence on lovastatin production by M. pilosus with a variety of biomasses, indicating high potential for such production. Based on these results, we also discuss the regulation of lovastatin biosynthesis in M. pilosus.
Materials and Methods
Strains and growth conditions. Cultures of M. pilosus IFO4520 (wild type) and mutant strains were maintained on PDA (potato dextrose agar; BD, Franklin Lakes, NJ). After growth on PDA for 10 d at 30 C, spores were harvested with a sterile solution (0.9% NaCl, 0.2% Tween 80), and approximately 10 7 spores were inoculated into 25 ml PD medium (potato dextrose broth; BD) and GGP medium (3% glucose, 7% glycerol, 3.8% peptone, 0.1% MgSO 4 . 7H 2 O, 0.2% NaNO 3 ) in 100 ml flasks. Liquid cultures were incubated at 25 C at 120 rpm for the indicated times. Carbon and nitrogen sources in GGP medium were modified as indicated. There was no large variation in initial pH of the media used (approximately pH 6.5), nor in the final pH of cultures (approximately pH 6-7).
Analytical methods. After growth in liquid culture, fermentation broth and cells were separated by filtration (No. 5C; Advantec, Tokyo, Japan). Biomass was determined based on the dry-weight (dw) of the filtrated cells from cultures. Fermentation broth was assayed for lovastatin production after filtration using membrane filters (pore size, 0.45 mM). Lovastatin content in the fermentation broth was determined by chromatograms detected at 237 nm under established conditions, as described previously, 14) and the peak of the statin was identified by mass spectra. All data presented are the averages of results obtained from three independent measurements.
Observation of morphological development. To observe the morphological development of mutant strains, plate cultures were grown for 7 d or more at 30 C. After culturing, colonies, mycelia, and spores present on plates were observed directly under a light microscope.
Mutant isolation. Monascus species in general have a teleomorphic life cycle, in which recessive phenotypes tend to be complemented and dominant phenotypes tend to be condensed through generations. We adopted a scheme using liquid culture combined with drug tolerance for positive selection of dominant mutations. In order to select spontaneous regulatory mutants in lovastatin production, cultivation and screening were carried out in PD medium causing low or repressive production. After treatment with N-methyl-N 0 -nitro-Nnitrosoguanidine (the survival rate was several percent), spores of M. pilosus IFO4520 were inoculated and cultivated at 30 C in PD medium containing cerulenin, an inhibitor of general polyketide synthases at 20-100 mg/l, because cerulenin tolerance might mean an increase in polyketide synthases or the development of resistance to inhibition. After repeated subculturing at intervals of several days, we finally isolated several cerulenin tolerant mutants. In the first screening, the mutants obtained were assayed for lovastatin production after 14 d of growth at 25 C in PD medium. One mutant, designated MK-1, which showed maximum lovastatin productivity, 5-fold higher than that of the wild type, was selected for further experiments. The M. pilosus mutant MK-1 was isolated from subcultures containing cerulenin at 50 mg/l, and showed tolerance to cerulenin at up to 100 mg/l.
Results

Effects of nitrogen sources on lovastatin production
In general, M. pilosus can produce moderate amounts of lovastatin (approximately 130 mg/l) in glucoseglycerol-peptone (GGP) medium after biomass formation, though it requires a longer growth period than other lovastatin producing species such as A. terreus. First, peptone in GGP medium was replaced with several nitrogen sources: nitrate is one of the standard inorganic nitrogen sources for filamentous fungi, glutamate is one of simple organic nitrogen sources generally selected for lovastatin production of A. terreus and red pigment production of Monascus species, 7, 15) and tryptone is another major complex organic nitrogen source for filamentous fungi. But growth of M. pilosus on nitrate and glutamate was very poor and no lovastatin was detected, and tryptone did not contribute to lovastatin production despite a well-formed biomass (data not shown). Hence we redefined peptone as an organic nitrogen source for lovastatin production in this study. We also examined the effect of peptone concentration in GGP medium on lovastatin production. As shown in Table 1 , 3.8% peptone, the original concentration in GGP medium, was re-established for high lovastatin production with suitable biomass. Lower concentrations of peptone led to production, but with unsuitable biomass levels. A higher concentration of peptone strongly repressed production. We concluded that M. pilosus requires a suitable concentration of organic nitrogen peptone for high lovastatin production and growth.
Effects of carbon sources on lovastatin production
The effects of sole carbon sources combined with 3.8% peptone on lovastatin production were determined. Because the secondary metabolism of filamentous fungi in general is commonly regulated by glucose repression, three types of carbon sources of such repression were tested for lovastatin production by M. pilosus: glucose as a repressive carbon source, maltose and fructose as moderately repressive carbon sources, and glycerol and lactose as non-repressive carbon sources. The effects of all carbon sources tested on lovastatin production were dose-dependent up to 7%, positively or negatively. Repressing carbon source glucose was shown to repress lovastatin production strongly (Table 2) . Moderately repressing carbon sources maltose and fructose led to high and intermediate production at a concentration of 7% (Table 2) . Non-repressing carbon source glycerol led to a slight but noticeable increase in lovastatin production as compared to glucose, although lactose was not utilized for growth. Moreover, it is interesting that combinations of carbon sources (maltose and glucose combined with glycerol) resulted in enhanced lovastatin production (Table 3 ). In this series of experiments, the highest production, 444 mg/l, was achieved in the presence of 1% maltose-7% glycerol. These results show that an appropriate selection of type and dose of carbon sources, including combinations, to avoid strong repression by glucose is required for higher lovastatin production by M. pilosus.
Relationship of C/N ratio and lovastatin production
The above results, shown in Tables 1 and 3 , suggest that lovastatin production by M. pilosus requires a medium with a suitable C/N ratio. Hence, the effect of the peptone concentration (0.1-3.8%) in 1% maltose-7% glycerol medium was also determined, and the C/N ratios for all conditions used in this study were calculated and plotted against relative lovastatin production. The highest value under any one condition with one variable was set at 100%. It was discovered that a suitable C/N ratio for lovastatin production was from 7 to 9 (Fig. 1) . Even in the presence of glucose, which strongly represses production, the most suitable C/N ratio was close to from 7 to 9.
A mutant with increased lovastatin production Lovastatin production by M. pilosus was shown to be strongly repressed in the presence of glucose. In order to relieve this repression spontaneously, we isolated a mutant called MK-1 that had 5-fold higher lovastatin production in PD medium than the wild type (see ''Materials and Methods''). With respect to the morphological characteristics of M. pilosus mutant MK-1, the strain formed small red-appearing colonies and produced higher red pigments and more spores from more branching mycelia on PDA in the short term than the wild type (data not shown). Interestingly, there were apparently higher differences in lovastatin production ability by the M. pilosus mutant MK-1 in the presence of glucose than in the parent, although lovastatin levels by M. pilosus mutant MK-1 grown in the medium without glucose tested in this study were also a little higher than those of the wild type (data not shown). Especially, in GGP medium, M. pilosus mutant MK-1 produced the highest amount of lovastatin: up to 725 mg/l (Fig. 2) . Additionally, biomass formation by M. pilosus mutant MK-1 in tested cultures was relatively low as compared with the wild type (data not shown). Based on these results, we propose that glucose repression and feedback inhibition of lovastatin production was substantially relieved in M. pilosus mutant MK-1. Moreover, differences in the cell development of this mutant might hasten lovastatin production based on signals of growth.
Discussion
In this study, the type and dose of carbon and nitrogen sources strongly influenced lovastatin production by M. pilosus. M. pilosus produced very little lovastatin grown on glucose, which commonly represses secondary metabolite production. We believe that lovastatin biosynthesis in M. pilosus is regulated by stricter glucose repression than in A. terreus and other Monascus species because they can relatively easily produce more lovastatin grown even on glucose. 7) Glucose repression in Aspergillus is mediated mainly by CreA as a repressor to expression of genes involved in the utilization of alternative carbons, and CreA might also be involved in lovastatin biosynthesis. 7) Maltose and fructose do not activate CreA strongly, and glycerol does not at all. The onset of lovastatin production by M. pilosus in these carbon sources can be explained by the mediation of CreA, which M. pilosus might also have. Maltose led to higher induction of lovastatin production than did fructose or glycerol. Limitation of carbon assimilation for growth is required for initiation of secondary metabolite production, 7) which explains this phenomenon. Maltose is slowly metabolized, and this condition can mimic limitation of carbon assimilation during growth, while fructose and glycerol are rapidly metabolized and a limited condition of carbon assimilation must arise after growth. Interestingly, glycerol in combination with glucose appears to relax strict glucose repression by glucose only, because growth must depend on earlier glucose consumption and a relatively large amount of glycerol, a non-repressing carbon, can remain in the limited condition of carbon assimilation after growth. Glycerol in combination with maltose enhanced further induction of lovastatin production. In this case, the growth must depend mainly on rapidly metabolized glycerol, and thus lower levels of maltose can more closely mimic limitation of carbon assimilation during growth, which explains how 1% maltose-7% glycerol was most effective condition. A similar benefit of high lovastatin production by a combination of a rapidly and a slowly metabolized carbon was also found in Aspergillus.
7) The nitrogen source is another significant limiting factor influencing the regulation of lovastatin biosynthesis via growth. Among several nitrogen sources tested, peptone was better for lovastatin production by M. pilosus; this is one reason that the growth of M. pilosus was largely dependent on the type of nitrogen source. Moreover, a suitable concentration of peptone was important for high production. Low biomass by lower peptone concentration resulted in the reduction of total production. In the case of higher peptone concentration, non-limitation of nitrogen and consumption of carbon sources might repress lovastatin biosynthesis and reduce the statin's production, respectively. The stricter regulation by carbon and nitrogen of lovastatin biosynthesis by M. pilosus well reflected the suitable C/N ratio calculated in this study, from 7 to 9, very narrow, and lower than other lovastatin producing species.
From the above, M. pilosus has mechanisms for regulating lovastatin biosynthesis similar to those of A. terreus, such as those at the level of glucose repression and via signals of growth or substrate limitations. 7, 8) The details, however, are a little different and control is tighter. In GGP medium, lovastatin production by M. pilosus appears to be initiated after C/N ratios of the conditions used in this study were calculated and plotted against relative activities of lovastatin production, and the highest value at one variable was set at 100%. indicates various conditions except in the presence of glucose; and indicate conditions containing glucose-glycerol-peptone under which the peptone and glycerol concentrations were set and glucose was variable, and the glucose and glycerol concentrations were set and the peptone concentration varied, respectively. The C-contents (% by dry weight) of glucose, maltose, fructose, glycerol, and lactose were 39. C in GGP medium (3% glucose, 7% glycerol, 3.8% peptone), the lovastatin levels in the fermentation broth were determined. similar effect of feedback inhibition has been reported in A. terreus. 16) This productivity was elevated 3-fold, up to 444 mg/l, the highest level reported in liquid culture of wild strains, 9) by appropriate selection of carbon and nitrogen sources with a suitably designed C/N ratio. This highest achieved productivity also indicates the high potential for lovastatin production by M. pilosus, thought so far to have a relatively low ability. Moreover, it should be emphasized that this productivity under strict glucose repression can be greatly elevated, to 725 mg/l, by a mutation(s) in M. pilosus mutant MK-1. The lovastatin levels of this mutant grown in a medium containing glucose were especially higher from those of the wild type, strongly implying that glucose repression can be relieved in this mutant. Taken together, we propose that an appropriate release from strict glucose repression by optimizing medium compositions and/or by a mutation(s) is required for high lovastatin production by M. pilosus.
M. pilosus mutant MK-1 might also have a mutation(s) in cell development with respect to morphological characteristics, and have the ability to produce higher levels of red pigments, which are also polyketides. These morphological and metabolic characteristics of MK-1 suggest that cell development has a significant relationship with secondary metabolism (including polyketide synthesis) in M. pilosus, as in the welldescribed fungus A. nidulans. 17) We expect that differences in signal transduction during cell development in M. pilosus mutant MK-1 can result in derepression or activation of polyketide synthesis under glucose repression via some factor operating upstream of this synthesis. Recently, LaeA, a global transcriptional regulator of secondary metabolism in Aspergillus species, was identified and characterized. 18) LaeA has features of a nuclear protein methyltransferase, is localized in the nucleus, and has been shown to up-regulate the expression of gene clusters for various secondary metabolites, including sterigmatocystin synthesis, penicillin synthesis, hyphal pigment production, and lovastatin synthesis (heterologous expression). LaeA expression is negatively regulated by two signal transduction elements, protein kinase A and Ras A, these are involved in cell development and also negatively regulate sporulation. Interestingly, delta-laeA mutants showed little difference in spore production as compared with wild type controls, suggesting a role for LaeA in the regulation of metabolic gene clusters. It should also be mentioned that LaeA homologs appear to be present only in the genomes of filamentous fungi. Hence, it will be of interest to identify the LaeA homolog in M. pilosus. Additionally, in M. pilosus, the role of a protein kinase(s) in cell development must be elucidated because little is known about cell development regulation and its relationship with secondary metabolism. Experiments to investigate these issues have been described elsewhere (Zhang and Miyake, submitted; Miyake et al., submitted).
